Related Experiment Video

Updated: Jun 16, 2026

Endoscopic Endonasal Trans-sphenoidal Approach: Minimally Invasive Surgery for Pituitary Adenomas
07:43

Endoscopic Endonasal Trans-sphenoidal Approach: Minimally Invasive Surgery for Pituitary Adenomas

Published on: January 17, 2018

Mortality in patients with pituitary disease

Mark Sherlock1, John Ayuk, Jeremy W Tomlinson

  • 1Centre for Endocrinology, Diabetes, and Metabolism, School of Clinical and Experimental Medicine, College of Medical and Dental Sciences, University of Birmingham, Birmingham B15 2TH, United Kingdom.

Endocrine Reviews
|January 21, 2010
PubMed

Insights

Pituitary diseases increase mortality, mainly from vascular causes. Better control of hormone secretion and cardiovascular risk factors is crucial for improving patient outcomes and reducing death rates.

Area of Science:

  • Endocrinology
  • Oncology
  • Cardiovascular Medicine

Background:

  • Pituitary diseases are linked to higher mortality, primarily due to vascular complications.
  • Effective management of hormone hypersecretion, such as cortisol and growth hormone (GH), is vital for reducing mortality in Cushing's disease and acromegaly.
  • Pituitary hormone deficiencies and treatments like radiotherapy can negatively impact patient outcomes.

Purpose of the Study:

  • To review the factors contributing to increased mortality in pituitary disease.
  • To highlight the importance of managing hormone secretion and cardiovascular risk factors.
  • To identify areas for future research, particularly for craniopharyngioma.

Main Methods:

  • Retrospective analysis of mortality data in pituitary disease patients.
  • Review of factors influencing outcomes, including hormone control and treatment modalities.
  • Identification of specific patient groups with elevated mortality risks.

Main Results:

  • Vascular disease is the predominant cause of mortality in pituitary disease.
  • Control of cortisol and GH hypersecretion is key for reducing mortality in Cushing's disease and acromegaly.
  • Pituitary radiotherapy is associated with increased cerebrovascular mortality.

Conclusions:

  • Despite falling mortality rates, pituitary disease patients still face elevated risks.
  • Optimizing treatment strategies and further research are needed to improve long-term outcomes.
  • Craniopharyngioma patients require focused research to mitigate mortality risks from the tumor and its treatment.

More Related Videos

Development of Organoids from Mouse Pituitary as In Vitro Model to Explore Pituitary Stem Cell Biology09:48

Development of Organoids from Mouse Pituitary as In Vitro Model to Explore Pituitary Stem Cell Biology

Published on: February 25, 2022

Related Concept Videos

Major Hormones and Their Functions01:27

Major Hormones and Their Functions

Hormones, the biochemical messengers produced by endocrine glands, are pivotal in regulating bodily functions and maintaining homeostasis. Each hormone's balance is crucial; imbalances can lead to significant physiological disruptions. Major hormones include oxytocin, cortisol, epinephrine, estrogen, testosterone, thyroxine, growth hormone, insulin, and glucagon.
Oxytocin, produced in the hypothalamus and released by the pituitary gland, plays a role in social bonding, childbirth, and lactation.
Hypothyroidism II: Pathophysiology01:23

Hypothyroidism II: Pathophysiology

Hypothyroidism is a disorder characterized by insufficient production of thyroid hormones, which regulate metabolism, energy balance, and multiple organ systems.TypesHypothyroidism is classified based on the level of dysfunction. Primary hypothyroidism results from intrinsic thyroid gland dysfunction, causing reduced hormone production despite normal or increased stimulation. Secondary hypothyroidism arises from inadequate thyroid-stimulating hormone (TSH) secretion by the pituitary. Tertiary...
Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
Cushing Syndrome II: Pathophysiology01:19

Cushing Syndrome II: Pathophysiology

Cortisol production is normally governed by the hypothalamic–pituitary–adrenal (HPA) axis, which maintains hormonal balance through tightly regulated feedback mechanisms. Disruption of this regulatory system is central to the development of Cushing syndrome, whether the excess cortisol originates from external medications or internal pathology. Persistent cortisol elevation alters metabolism, immune function, and endocrine signaling, producing the characteristic clinical features of the...
Graves Disease II: Pathophysiology01:24

Graves Disease II: Pathophysiology

Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...
The Pituitary Gland01:17

The Pituitary Gland

The pituitary is a small endocrine organ in the sphenoid bone under the hypothalamus. Primarily, the pituitary in adults has two distinct anatomical and functional regions— the anterior and posterior lobes. During human fetal development, a third pituitary gland region called the pars intermedia atrophies and disappears. However, some of its cells migrate and exist adjacent to the anterior pituitary in adults.